Related Experiment Video
Updated: Aug 1, 2026
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Response to chemotherapy of a radiation-induced glioblastoma multiforme
Linda Nicolardi1, Lisa M DeAngelis
1School of Medicine, Padua University, Padua, Italy.
Background:
Radiation-induced glioblastoma multiforme (GBM) is particularly resistant to treatment and therapeutic options are limited. We report a patient with a radiation-induced GBM who had a complete response to carmustine and survived for 44 months.
Patients And Methods:
Case report of a 38-year-old man with a radiation-induced GBM that responded to carmustine.
Results:
Our patient developed a left occipital GBM 35 years after a left cerebellar astrocytoma was treated with surgery and radiation therapy (4500 rad). The GBM was treated with subtotal resection followed by four cycles of carmustine; a complete response was achieved. He relapsed 34 months after diagnosis and with further surgery survived 44 months from his diagnosis of GBM.
Conclusion:
GBMs may be a late complication of radiation treatment for pediatric brain tumors. If further radiotherapy is not a therapeutic option, chemotherapy may result in prolonged survival.
